{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T17:42:48Z","timestamp":1792086168096,"version":"4.4.0"},"reference-count":98,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,1,18]],"date-time":"2014-01-18T00:00:00Z","timestamp":1390003200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1471-2334-14-33","type":"journal-article","created":{"date-parts":[[2014,1,18]],"date-time":"2014-01-18T20:08:32Z","timestamp":1390075712000},"source":"Crossref","is-referenced-by-count":68,"title":["Congenital toxoplasmosis and prenatal care state programs"],"prefix":"10.1186","volume":"14","author":[{"given":"Mariza M","family":"Avelino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waldemar N","family":"Amaral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isolina MX","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan R","family":"Rassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria BF","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiane L","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana M","family":"Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,1,18]]},"reference":[{"key":"4167_CR1","first-page":"41","volume-title":"Human toxoplasmosis.Volume 2","author":"HF Eichenwald","year":"1959","unstructured":"Eichenwald HF: A study of congenital toxoplasmosis with a particular emphasis on clinical manifestations, sequelae and therapy. Human toxoplasmosis.Volume 2. Edited by: Siim JC. 1959, Copenhagen: Munksgaard, 41-49."},{"issue":"20","key":"4167_CR2","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1056\/NEJM197405162902003","volume":"290","author":"G Desmonts","year":"1974","unstructured":"Desmonts G, Couvreur J: Congenital toxoplasmosis. A prospective study of 378 pregnancies. New Engl J Med. 1974, 290 (20): 1110-1116. 10.1056\/NEJM197405162902003.","journal-title":"New Engl J Med"},{"key":"4167_CR3","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/S0140-6736(86)90785-3","volume":"1","author":"JG Koppe","year":"1986","unstructured":"Koppe JG, Loewer SDH, Roever BH: Results of 20 years follow-up congenital toxoplasmosis. Lancet. 1986, 1: 254-256.","journal-title":"Lancet"},{"key":"4167_CR4","first-page":"653","volume-title":"Therapy of infectious diseases","author":"E Petrof","year":"2002","unstructured":"Petrof E: McLeod R. Toxoplasma gondii and Toxoplasmosis. Therapy of infectious diseases. Edited by: Badour L, Gorbach S. 2002, Philadelphia: WB Saunders, 653-696."},{"key":"4167_CR5","first-page":"915","volume-title":"Infectious diseases of the fetus and newborn infant","author":"JS Remington","year":"2011","unstructured":"Remington JS, Mc Leod R, Wilson CB, Desmonts G: Toxoplasmosis. Infectious diseases of the fetus and newborn infant. Edited by: Remington JS, Klein JO, Wilson CB, Nizet V, Maldonado YA. 2011, Pennsylvania: Elsevier Saunders, 915-1041. 7","edition":"7"},{"key":"4167_CR6","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1093\/clinids\/18.1.38","volume":"18","author":"J McAuley","year":"1994","unstructured":"McAuley J, Boyer KM, Patel D, Mets M, Swisher C, Roizen N, Wolters C, Stein L, Stein M, Schey W: Early and longitudinal evaluations of treated infants and children and untreated historical patients with congenital toxoplasmosis: The Chicago collaborative treatment trial. Clin Infect Dis. 1994, 18: 38-72. 10.1093\/clinids\/18.1.38.","journal-title":"Clin Infect Dis"},{"key":"4167_CR7","first-page":"2954","volume-title":"Textbook of pediatric infectious diseases, volume 235","author":"JB McAuley","year":"2009","unstructured":"McAuley JB, Boyer K, Remington JS, McLeod R: Toxoplasmosis. Textbook of pediatric infectious diseases, volume 235. 2009, United States of America: Saunders Elsevier, 2954-2971. 6","edition":"6"},{"key":"4167_CR8","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.ajo.2008.04.033","volume":"146","author":"L Phan","year":"2008","unstructured":"Phan L, Kasza K, Jalbrzikowski J, Noble AG, Latkany P, Kuo A, Mieler W, Meyers S, Rabiah P, Boyer K, Swisher C, Mets M, Roizen N, Cezar S, Sautter M, Remington J, Meier P, McLeod R: Longitudinal study of new eye lesions in children with toxoplasmosis who were not treated during the first year of life. Am J Ophthalmol. 2008, 146: 375-384. 10.1016\/j.ajo.2008.04.033.","journal-title":"Am J Ophthalmol"},{"key":"4167_CR9","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/S0002-9394(02)01704-X","volume":"135","author":"AP Br\u00e9zin","year":"2003","unstructured":"Br\u00e9zin AP, Thulliez P, Couvreur J, Nobr\u00e9 R, Mcleod R, Mets MB: Ophthalmic outcomes after prenatal and postnatal treatment of congenital toxoplasmosis. Am J Ophthalmol. 2003, 135: 779-784. 10.1016\/S0002-9394(02)01704-X.","journal-title":"Am J Ophthalmol"},{"key":"4167_CR10","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1542\/peds.66.5.767","volume":"66","author":"CB Wilson","year":"1980","unstructured":"Wilson CB, Remington JS, Stagno S, Reynolds DW: Development of adverse sequelae in children born with subclinical congenital Toxoplasma infection. Pediatrics. 1980, 66: 767-774.","journal-title":"Pediatrics"},{"key":"4167_CR11","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/S0002-9378(99)70224-3","volume":"180","author":"W Foulon","year":"1999","unstructured":"Foulon W, Villena I, Stray-Pedersen B, Decoster A, Lappalainen M, Pinon JM, Jenum PA, Hedman K, Naessens A: Treatment of toxoplasmosis during pregnancy: a multicenter study of impact on fetal transmission and children\u2019s sequelae at one year of age. Am J Obstet Gynecol. 1999, 180: 410-415. 10.1016\/S0002-9378(99)70224-3.","journal-title":"Am J Obstet Gynecol"},{"key":"4167_CR12","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1086\/501360","volume":"42","author":"R McLeod","year":"2006","unstructured":"McLeod R, Boyer K, Karrison T, Kasza K, Swisher C, Roizen N, Jalbrzikowski J, Remington J, Heydemann P, Noble AG, Mets M, Holfels E, Withers S, Latkany P, Meier P: Outcome of treatment for congenital toxoplasmosis, 1981\u20132004: The national collaborative Chicago-based, congenital toxoplasmosis study. Clin Infect Dis. 2006, 42: 1383-1394. 10.1086\/501360.","journal-title":"Clin Infect Dis"},{"key":"4167_CR13","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1097\/INF.0b013e31820bb5f3","volume":"30","author":"F Peyron","year":"2011","unstructured":"Peyron F, Garweg JG, Wallon M, Descloux E, Rolland M, Barth J: Long-term impact of treated congenital toxoplasmosis on quality of life and visual performance. Pediatr Infect Dis. 2011, 30: 597-600. 10.1097\/INF.0b013e31820bb5f3.","journal-title":"Pediatr Infect Dis"},{"key":"4167_CR14","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1093\/ije\/30.6.1303","volume":"30","author":"RE Gilbert","year":"2001","unstructured":"Gilbert RE, Gras L, Wallon M, Peyron F, Ades AE, Dunn DT: Effect of prenatal treatment on mother to child transmission of Toxoplasma gondii: retrospective study of 554 mother-child pairs in Lyon, France. Int J Epidemiol. 2001, 30: 1303-1308. 10.1093\/ije\/30.6.1303.","journal-title":"Int J Epidemiol"},{"key":"4167_CR15","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1371\/journal.pntd.0000277","volume":"2","author":"RE Gilbert","year":"2008","unstructured":"Gilbert RE, Freeman K, Lago EG, Bahia-Oliveira LMG, Tan HK, Wallon M, Buffolano W, Stanford MR, Petersen E: Ocular sequelae of congenital toxoplasmosis in Brazil compared with Europe. PLoS Negl Trop Dis. 2008, 2: 277-10.1371\/journal.pntd.0000277.","journal-title":"PLoS Negl Trop Dis"},{"key":"4167_CR16","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1093\/ije\/30.6.1309","volume":"30","author":"L Gras","year":"2001","unstructured":"Gras L, Gilbert RE, Ades AE, Dunn DT: Effect of prenatal treatment on the risk of intracranial and ocular lesions in children with congenital toxoplasmosis. Inter J Epidemiol. 2001, 30: 1309-1313. 10.1093\/ije\/30.6.1309.","journal-title":"Inter J Epidemiol"},{"issue":"5","key":"4167_CR17","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/S0104-4230(11)70117-8","volume":"57","author":"RFM Lopes-Mori","year":"2011","unstructured":"Lopes-Mori RFM, Mitsuka-Bregan\u00f3 R, Capobiango JD, Teruo Inoue I, Reiche EMV, Morimoto HK, Casella AMB, Bittencourt LHFB, Freire RL, Navarro IT: Programs for control of congenital toxoplasmosis. Brazil Rev Med Ass. 2011, 57 (5): 581-586. 10.1016\/S0104-4230(11)70117-8. http:\/\/dx.doi.org\/101590\/S0104-43-2302001100500021 ,","journal-title":"Brazil Rev Med Ass"},{"issue":"2","key":"4167_CR18","first-page":"164","volume":"8","author":"MM Avelino","year":"2004","unstructured":"Avelino MM, Campos D, Parada JB, Castro AM: Risk factors for Toxoplasma gondii infection in women of childbearing age. BJID. 2004, 8 (2): 164-174.","journal-title":"BJID"},{"key":"4167_CR19","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S0301-2115(02)00353-6","volume":"108","author":"MM Avelino","year":"2003","unstructured":"Avelino MM, Campos D, Barbosa JCB, Castro AM: Pregnancy as a risk factor to acute toxoplasmosis seroconvertion. Eur J Obstet Gynecol Reprod Biol. 2003, 108: 19-24. 10.1016\/S0301-2115(02)00353-6.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"4167_CR20","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/0028-2243(92)90064-6","volume":"43","author":"M Daunter","year":"1992","unstructured":"Daunter M: Immunology of pregnancy: towards aunifynd hypotesys. Eur J Obstet Gynecol Reprod Biol. 1992, 43: 81-95. 10.1016\/0028-2243(92)90064-6.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"8","key":"4167_CR21","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1136\/adc.2004.066514","volume":"91","author":"DR Schmidt","year":"2006","unstructured":"Schmidt DR, Hogh B, Andersen O, Fuchs J, Fledelius H, Petersen E: The national neonatal screening programme for congenital toxoplasmosis in Denmark: results from the initial four years, 1999\u20132002. Arch Dis Child. 2006, 91 (8): 661-665. 10.1136\/adc.2004.066514.","journal-title":"Arch Dis Child"},{"issue":"11","key":"4167_CR22","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1017\/S0031182012000765","volume":"139","author":"JP Dubey","year":"2012","unstructured":"Dubey JP, Lago EG, Gennari SM, Su C, Jones JL: Toxoplasmosis in humans and animals in Brazil: high prevalence, high burden of disease, and epidemiology. Parasitology. 2012, 139 (11): 1375-1424. 10.1017\/S0031182012000765.","journal-title":"Parasitology"},{"issue":"3","key":"4167_CR23","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1515\/JPM.2004.039","volume":"32","author":"M Breugelmans","year":"2004","unstructured":"Breugelmans M, Naessens A, Foulon W: Prevention of toxoplasmosis during pregnancy an epidemiologic survey over 22 consecutive years. J Perinat Med. 2004, 32 (3): 211-214.","journal-title":"J Perinat Med"},{"issue":"12","key":"4167_CR24","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1097\/INF.0b013e3182343096","volume":"30","author":"TR Olariu","year":"2011","unstructured":"Olariu TR, Remington JS, McLeod R, Alam A, Montoya JG: Severe congenital toxoplasmosis in the United States: clinical and serologic findings in untreated infants. Pediatr Infect Dis J. 2011, 30 (12): 1056-1061. 10.1097\/INF.0b013e3182343096.","journal-title":"Pediatr Infect Dis J"},{"key":"4167_CR25","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1136\/jms.9.3.135","volume":"9","author":"RE Gilbert","year":"2002","unstructured":"Gilbert RE, Peckham CS: Congenital toxoplasmosis in the United Kingdom: to screen or not to screen?. J Med Screen. 2002, 9: 135-141. 10.1136\/jms.9.3.135.","journal-title":"J Med Screen"},{"issue":"4","key":"4167_CR26","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1093\/eurpub\/cks075","volume":"23","author":"A Flatt","year":"2013","unstructured":"Flatt A, Shetty N: Seroprevalence and risk factors for toxoplasmosis among antenatal women in London: a re-examination of risk in an ethnically diverse population. Eur Public Health. 2013, 23 (4): 648-652. 10.1093\/eurpub\/cks075.","journal-title":"Eur Public Health"},{"key":"4167_CR27","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/S1470-0328(02)02325-X","volume":"110","author":"R Gilbert","year":"2003","unstructured":"Gilbert R, Gras L: European Multicentre Study on congenital toxoplasmosis effect of timing and type of treatment on the risk of mother to child transmission of Toxoplasma gondii. BJOG. 2003, 110: 112-120.","journal-title":"BJOG"},{"key":"4167_CR28","volume-title":"Rev Cochrane Library","author":"F Peyron","year":"1999","unstructured":"Peyron F, Wallon M, Liou C, Garner P: Treatments for toxoplasmosis in pregnancy. Rev Cochrane Library. 1999, Issue 3, Art No. CD001684.DOI 10.1002\/14651858.CD001684"},{"key":"4167_CR29","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/B978-0-444-52910-7.00028-3","volume":"112","author":"R Thi\u00e9baut","year":"2013","unstructured":"Thi\u00e9baut R, Leproust S, Ch\u00eane G, Gilbert R: SYROCOT (Systematic Review on Congenital Toxoplasmosis) study group. Effectiveness of prenatal treatment for congenital toxoplasmosis: a meta-analysis of individual patients data. Handb Clin Neurol. 2013, 112: 1099-101. DOI:10.1016\/B978-0-444-52910-7.00028-3","journal-title":"Handb Clin Neurol"},{"key":"4167_CR30","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/B978-0-444-52910-7.00028-3","volume":"112","author":"F Kieffer","year":"2013","unstructured":"Kieffer F, Wallon M: Congenital toxoplasmosis. Handb Clin Nuerol. 2013, 112: 1099-1101. doi:10.1016\/B978-0-444-52910-7.00028-3","journal-title":"Handb Clin Nuerol"},{"issue":"9","key":"4167_CR31","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1371\/journal.pntd.0001333","volume":"5","author":"E Stillwaggon","year":"2011","unstructured":"Stillwaggon E, Carrier CS, Sautter M, McLeod R: Maternal serologic screening to prevent congenital toxoplasmosis: a decision-analytic economic model. PLoS Negl Trop Dis. 2011, 5 (9): 1333-10.1371\/journal.pntd.0001333. PMC3181241","journal-title":"PLoS Negl Trop Dis"},{"issue":"2","key":"4167_CR32","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1590\/S0074-02762009000200025","volume":"104","author":"C Genevi\u00e8ve","year":"2009","unstructured":"Genevi\u00e8ve C, Rodolphe T: Options for clinical trials of pre and post-natal treatments for congenital toxoplasmosis. Mem Inst Oswaldo Cruz. 2009, 104 (2): 299-304. 10.1590\/S0074-02762009000200025. http:\/\/dx.doi.org\/101590\/S0074-02762009000200025 ,","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"4167_CR33","first-page":"363","volume":"72","author":"W Foulon","year":"1988","unstructured":"Foulon W, Naessens A, Lauwers S, De Meuter F, Amy JJ: Impact of primary prevention on the incidence of toxoplasmosis during pregnancy. Obstet Gynecol. 1988, 72: 363-366.","journal-title":"Obstet Gynecol"},{"key":"4167_CR34","first-page":"330","volume":"19","author":"C Douche","year":"1996","unstructured":"Douche C, Benabdesselam A, Mokhtari F, Le Mer Y: Value of prevention of congenital toxoplasmosis. J Fr Ophtalmol. 1996, 19: 330-334.","journal-title":"J Fr Ophtalmol"},{"key":"4167_CR35","first-page":"249","volume":"5","author":"C Roux","year":"1976","unstructured":"Roux C, Desmonts G, Mulliez N, Gaulier M, Tufferaud G, Marmor D, Herbillon A: Toxoplasmosis and pregnancy. Evaluation of 2 years of prevention of congenital toxoplasmosis in the maternity ward of H\u00f4pital Saint-Antoine (1973\u20131974). J Gynecol Obstet Biol Reprod. 1976, 5: 249-264.","journal-title":"J Gynecol Obstet Biol Reprod"},{"key":"4167_CR36","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1080\/14767050412331312250","volume":"14","author":"M Ricci","year":"2003","unstructured":"Ricci M, Pentimalli H, Thaller R, rav\u00e0 L, Di Ciommo V: Screening and prevention of congenital toxoplasmosis: An effectiveness study in a population with a high infection rate. J Mat Fetal Neonatal Med. 2003, 14: 398-403. 10.1080\/14767050412331312250.","journal-title":"J Mat Fetal Neonatal Med"},{"key":"4167_CR37","doi-asserted-by":"crossref","unstructured":"Di Mario S, Basevi V, Gagliotti C, Spettoli D, Gori G, D\u2019Amico R, Magrini N: Prenatal education for congenital toxoplasmosis. Edited by: Cochrane Pregnancy and Childbirth Group. 2009, Cochrane Database Syst Rew 2013, Issue 2, Art No. 3 CD006171.DOI.1002\/14651858.CD006171 pub","DOI":"10.1002\/14651858.CD006171.pub2"},{"key":"4167_CR38","volume-title":"Treatment for congenital toxoplasmosis: finding out what works","author":"R Gilbert","year":"2009","unstructured":"Gilbert R: Treatment for congenital toxoplasmosis: finding out what works. Mem Inst Oswaldo Cruz. 2009, 104 (2): http:\/\/dx.doi.org\/101590\/S0074-02762009000200026 ,"},{"key":"4167_CR39","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1136\/bmj.318.7197.1511","volume":"318","author":"M Wallon","year":"1999","unstructured":"Wallon M, Liou C, Garner P, Fran\u00e7ois F: Congenital toxoplasmosis: systematic review of evidence of efficacy of treatment in pregnancy. BMJ. 1999, 318: 1511-10.1136\/bmj.318.7197.1511.","journal-title":"BMJ"},{"key":"4167_CR40","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1093\/ije\/30.6.1314","volume":"30","author":"A Eskild","year":"2001","unstructured":"Eskild A, Magnus P: Little evidence of effective prenatal treatment against congenital toxoplasmosis-the implications for testing in pregnancy. Int J Epidemiol. 2001, 30: 1314-1315. 10.1093\/ije\/30.6.1314.","journal-title":"Int J Epidemiol"},{"key":"4167_CR41","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.ajog.2004.07.031","volume":"192","author":"KM Boyer","year":"2005","unstructured":"Boyer KM, Holfels E, Roizen N, Swisher C, Mack D, Remington JS, Withers S, Meier P, McLeod R: Risk factors for Toxoplasma gondii infection in mothers of infants with congenital toxoplasmosis: Implications for prenatal management and screening. Am J Obstet Gynecol. 2005, 192: 564-571. 10.1016\/j.ajog.2004.07.031.","journal-title":"Am J Obstet Gynecol"},{"key":"4167_CR42","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1086\/590149","volume":"47","author":"JG Montoya","year":"2008","unstructured":"Montoya JG, Remington JS: Management of Toxoplasma gondii Infection during Pregnancy. Clin Infect Dis. 2008, 47: 554-566. 10.1086\/590149.","journal-title":"Clin Infect Dis"},{"issue":"Suppl","key":"4167_CR43","first-page":"43","volume":"84","author":"P Thulliez","year":"1992","unstructured":"Thulliez P: Screening programme for congenital toxoplasmosis in France. Scand J Infect Dis. 1992, 84 (Suppl): 43-45.","journal-title":"Scand J Infect Dis"},{"issue":"Suppl","key":"4167_CR44","first-page":"32","volume":"84","author":"H Aspock","year":"1992","unstructured":"Aspock H, Pollak A: Prevention of prenatal toxoplasmosis by serological screening of pregnant women in Austria. Scand J Infect Dis. 1992, 84 (Suppl): 32-77.","journal-title":"Scand J Infect Dis"},{"issue":"9","key":"4167_CR45","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1093\/cid\/cit032","volume":"56","author":"M Wallon","year":"2013","unstructured":"Wallon M, Peyron F, Cornu C, Vinault S, Abrahamowicz M, Bonithon C, Kopp C, Binquet C: Congenital toxoplasma infection: monthly prenatal screening decreases transmission rate and improves clinical outcome at age 3 years. Clin Infect Dis. 2013, 56 (9): 1223-1231. 10.1093\/cid\/cit032.","journal-title":"Clin Infect Dis"},{"key":"4167_CR46","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1080\/00365540110080386","volume":"34","author":"J Logar","year":"2002","unstructured":"Logar J, Petrovec M, Novak-Antolic Z, Premru-Srsen T, Cizman M, Arnez M, Kraut A: Prevention of congenital toxoplasmosis in Slovenia by serological screening of pregnant woman. Scand J Infect Dis. 2002, 34: 201-204. 10.1080\/00365540110080386.","journal-title":"Scand J Infect Dis"},{"key":"4167_CR47","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/S0022-3476(89)80660-2","volume":"115","author":"P Hohlfeld","year":"1989","unstructured":"Hohlfeld P, Daffos F, Thulliez P, Aufrant C, Couvreur J, Mac Alisee J, Descombey D: Fetal toxoplasmosis: outcome of pregnancy and infant follow-up after in utero treatment. J Pediatr. 1989, 115: 765-769. 10.1016\/S0022-3476(89)80660-2.","journal-title":"J Pediatr"},{"key":"4167_CR48","first-page":"1448","volume":"20","author":"F Forestier","year":"1991","unstructured":"Forestier F: Les foetopathies infectieuses: prevention, diagnostic prenatal, attitude pratique. Presse Med. 1991, 20: 1448-1454.","journal-title":"Presse Med"},{"key":"4167_CR49","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1017\/S0950268803001316","volume":"131","author":"C Binquet","year":"2003","unstructured":"Binquet C, Wallon M, Quantin C, Kodjikian L, Garweg J, Fleury J, Peyron F, Abrahamow M: Prognostic factors for the long-term development of ocular lesions in 327 children with congenital toxoplasmosis. Epidemiol Infect. 2003, 131: 1157-1168. 10.1017\/S0950268803001316.","journal-title":"Epidemiol Infect"},{"issue":"11","key":"4167_CR50","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1093\/cid\/cis234","volume":"54","author":"A Hotop","year":"2012","unstructured":"Hotop A, Hlobil H, Gro\u00df U: Efficacy of rapid treatment initiation following primary toxoplasma gondii infection during pregnancy. Clin Infect Dis. 2012, 54 (11): 1545-1552. 10.1093\/cid\/cis234.","journal-title":"Clin Infect Dis"},{"key":"4167_CR51","volume-title":"European Multicenter Study on Congenital Toxoplasmosis (EMSCOT). Prenatal treatment for serious neurological sequelae of congenital toxoplasmosis: an observational prospective cohort study","author":"M Cortina Borja","year":"2010","unstructured":"Cortina Borja M, Tan HK, Wallon M, Paul M, Prusa A, Buffolano W, Malm G, Salt A, Freeman K, Petersen E, Gilbert RE, et al: European Multicenter Study on Congenital Toxoplasmosis (EMSCOT). Prenatal treatment for serious neurological sequelae of congenital toxoplasmosis: an observational prospective cohort study. PloS Med. 2010, 7 (10): doi:10.1371\/journal.pmed1000351"},{"issue":"1","key":"4167_CR52","doi-asserted-by":"crossref","first-page":"35","DOI":"10.15448\/1980-6108.2010.1.6000","volume":"20","author":"V Meroni","year":"2010","unstructured":"Meroni V, Genco F: Screening for toxoplasmosis during pregnancy: one-year experience in an Italian reference laboratory. Scientia Med. 2010, 20 (1): 35-39.","journal-title":"Scientia Med"},{"key":"4167_CR53","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1111\/j.1469-0691.2006.01513.x","volume":"12","author":"D Nowakowska","year":"2006","unstructured":"Nowakowska D, Stray-Pedersen B, Spiewark E, Sobala W, Matafiej E, Wilczynski J: Prevalence and estimated incidence of Toxoplasma infection among pregnant women in Poland: a decreasing trend in the younger population. Clin Microbiol Infect. 2006, 12: 913-917. 10.1111\/j.1469-0691.2006.01513.x.","journal-title":"Clin Microbiol Infect"},{"issue":"12","key":"4167_CR54","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1080\/08035250500251999","volume":"94","author":"L Gras","year":"2005","unstructured":"Gras L, Wallon M, Pollak A, Cortina-Borja M, Evengard B, Hayde M, Petersen E, Gilbert R: European Multicenter Study on Congenital Toxoplasmosis. Association between prenatal treatment and clinical manifestations of congenital toxoplasmosis in infancy: a cohort study in 13 European centres. Acta Paediatr. 2005, 94 (12): 1721-1731. 10.1080\/08035250500251999.","journal-title":"Acta Paediatr"},{"key":"4167_CR55","doi-asserted-by":"publisher","first-page":"265","DOI":"10.3109\/00365549509019020","volume":"27","author":"M Lappalainen","year":"1995","unstructured":"Lappalainen M, Sintonen H, Koskiniemi M, Hedman K, Hiilesmaa V, Ammala P, Teramo K, Koskela P: Cost-benefit analysis of screening for toxoplasmosis during pregnancy. Scand J Infect Dis. 1995, 27: 265-272. 10.3109\/00365549509019020.","journal-title":"Scand J Infect Dis"},{"issue":"1e Suppl A)","key":"4167_CR56","first-page":"S1","volume":"35","author":"C Paquet","year":"2013","unstructured":"Paquet C, Yudin MH, Allen VM, Bouchard C, Boucher M, Caddy S, Paquet C, Yudin MH, Allen VM, Bouchard C, Boucher M, Caddy S, Castillo E, Money DM, Murphy KE, Ogilvie G, van Schalkwyk J: Toxoplasmosis in pregnancy:prevention, screening, and treatment. J Obstet Gynaecol Can. 2013, 35 (1e Suppl A)): S1-S7.","journal-title":"J Obstet Gynaecol Can"},{"key":"4167_CR57","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1159\/000106352","volume":"22","author":"E Galanakis","year":"2007","unstructured":"Galanakis E, Manoura A, Antoniou M, Sifakis S, Korakaki E, Hatzidaki E, Lambraki D, Tselentis Y, Giannakopoulou C: Outcome of toxoplasmosis acquired during pregnancy following treatment in both pregnancy and early infancy. Fetal Diagn Ther. 2007, 22: 444-448. 10.1159\/000106352. doi:10.1159\/000106352","journal-title":"Fetal Diagn Ther"},{"issue":"7","key":"4167_CR58","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1586\/eri.12.58","volume":"10","author":"PA Moncada","year":"2012","unstructured":"Moncada PA, Montoya JG: Toxoplasmosis in the fetus and newborn: an update on prevalence, diagnosis and treatment. Expert Rev Anti Infect Ther. 2012, 10 (7): 815-828. 10.1586\/eri.12.58. doi:10.1586\/eri.12,58","journal-title":"Expert Rev Anti Infect Ther"},{"key":"4167_CR59","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1093\/ije\/30.6.1315","volume":"30","author":"P Thulliez","year":"2001","unstructured":"Thulliez P: Commentary: efficacy of prenatal treatment for toxoplasmosis: a possibility that cannot be ruled out. Int J Epidemiol. 2001, 30: 1315-1316. 10.1093\/ije\/30.6.1315.","journal-title":"Int J Epidemiol"},{"issue":"1","key":"4167_CR60","first-page":"81","volume":"40","author":"M Lappalainen","year":"2004","unstructured":"Lappalainen M, Hedman K: Serodiagnosis of toxoplasmosis. The impact of measurement of IgG avidity. Ann Ist Super Sanita. 2004, 40 (1): 81-8.","journal-title":"Ann Ist Super Sanita"},{"issue":"8","key":"4167_CR61","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1128\/JCM.35.8.1972-1977.1997","volume":"35","author":"PA Jenun","year":"1997","unstructured":"Jenun PA, Stray PB, Gundersen AG: Improved diagnosis of primary Toxoplasma gondii infection in early pregnancy by determination of antitoxoplasma immunoglobulin G avidity. J Clin Microbiol. 1997, 35 (8): 1972-1977.","journal-title":"J Clin Microbiol"},{"key":"4167_CR62","first-page":"477","volume":"24","author":"TO Werblin","year":"1973","unstructured":"Werblin TO, Kim YT, Quagliata F, Siskind GW: Studies on the control of antibody synthesis. Changes in heterogeneity of antibody affinity during the course of the immune response. Immunology. 1973, 24: 477-492.","journal-title":"Immunology"},{"key":"4167_CR63","first-page":"60","volume-title":"[Port]. An\u00e1lise comparativa entre testes ELISA convencional (soro) e papel filtro (sangue seco) para detec\u00e7\u00e3o de IgM anti. Toxoplasma. Comparative analysis between conventional ELISA (serum) and filter paper (dried blood) for detection of IgM anti-Toxoplas","author":"ALM Minuzzi","year":"2008","unstructured":"Minuzzi ALM: [Port]. An\u00e1lise comparativa entre testes ELISA convencional (soro) e papel filtro (sangue seco) para detec\u00e7\u00e3o de IgM anti. Toxoplasma. Comparative analysis between conventional ELISA (serum) and filter paper (dried blood) for detection of IgM anti-Toxoplasma. 2008, Brasilia, Brazil: Master\u2019s thesis, Faculty of Health Sciences, University of Brasilia, 60-"},{"issue":"8","key":"4167_CR64","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1590\/S0100-72032005000800002","volume":"27","author":"EA Figueir\u00f3-Filho","year":"2005","unstructured":"Figueir\u00f3-Filho EA, Lopes AHA, Selefonte FRA, Souza J\u00fanior VG, Carlos Augusto Botelho CA, Figueiredo MS, Duarte G: Toxoplasmose aguda: estudo da frequ\u00eancia, taxa de transmiss\u00e3o vertical e rela\u00e7\u00e3o entre os testes diagn\u00f3sticos materno fetais em gestantes em estudo da Regi\u00e3o Centro Oeste do Brasil. Rev Bras Ginecol Obstet. 2005, 27 (8): 442-449.","journal-title":"Rev Bras Ginecol Obstet"},{"issue":"1","key":"4167_CR65","first-page":"47","volume":"12","author":"MG Silva","year":"2008","unstructured":"Silva MG, Junior RSL, Costa TL, Soares JDH, Amaral WN, Avelino MM, Castro AM: Anatomophathological study in BALB\/c mice brains experimentally infected with Toxoplasma gondii. BJID. 2008, 12 (1): 47-51.","journal-title":"BJID"},{"key":"4167_CR66","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1007\/BF00202486","volume":"90","author":"FR Santos","year":"1993","unstructured":"Santos FR, Pena SDJ, Epplen JT: Genetic and population study of a y-linked tetranucleotide repect DNA polymorphism with a simple non-isotopic technique. Hum Genetics. 1993, 90: 655-656.","journal-title":"Hum Genetics"},{"issue":"4","key":"4167_CR67","first-page":"227","volume":"18","author":"ME Camargo","year":"1976","unstructured":"Camargo ME, Leser PG: Diagnostic information from serological tests in human toxoplasmosis. II Evolutive study of antibodies and serological patterns in acquired toxoplasmosis, as detected by hemagglutination, complement fixation, IgG and IgM-immunofluorescence tests. Rev Inst Med Trop Sao Paulo. 1976, 18 (4): 227-238. doi:4","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"4167_CR68","first-page":"117","volume":"6","author":"ME Camargo","year":"1964","unstructured":"Camargo ME: Improved technique of indirect immunofluorescence for serological diagnosis of toxoplasmosis. Rev Inst Med Trop S Paulo. 1964, 6: 117-118.","journal-title":"Rev Inst Med Trop S Paulo"},{"issue":"3","key":"4167_CR69","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1590\/S0074-02762009000300006","volume":"104","author":"IMX Rodrigues","year":"2009","unstructured":"Rodrigues IMX, Castro AM, Gomes MBF, Amaral WN, Avelino MM: Congenital toxoplasmosis: evaluation of serologic. Mem Inst Oswaldo Cruz. 2009, 104 (3): 434-440. 10.1590\/S0074-02762009000300006.","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"4167_CR70","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1093\/jac\/22.2.193","volume":"22","author":"J Couvreur","year":"1988","unstructured":"Couvreur J, Desmonts G, Thulliez P: Prophylaxis of congenital toxoplasmosis: effects of spiramycin on placental infection. J Antimicrob Chemother. 1988, 22: 193-200. 10.1093\/jac\/22.2.193.","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"4167_CR71","first-page":"397","volume":"48","author":"J Couvreur","year":"1991","unstructured":"Couvreur J, Thulliez P, Daffos F, Aufrant C, Bompard Y, Gesqui\u00e9re A, Desmonts G: Fetal toxoplasmosis. In utero treatment with pyrimethamine sulfamides. Arch Fr Pediatr. 1991, 48 (6): 397-403.","journal-title":"Arch Fr Pediatr"},{"issue":"3","key":"4167_CR72","first-page":"325","volume":"8","author":"MM Avelino","year":"2009","unstructured":"Avelino MM, Parada JCB, Castro AM, Alves MFC, Campos D: Toxoplasma gondii primary infection in pregnant women in Goi\u00e2nia: a seroconversion study. J Med Biol Sci. 2009, 8 (3): 325-333.","journal-title":"J Med Biol Sci"},{"key":"4167_CR73","first-page":"5","volume":"S","author":"U Sagel","year":"2013","unstructured":"Sagel U, Kr\u00e4mer A: Screening of Maternal Toxoplasmosis in Pregnancy: Laboratory Diagnostics from the Perspective of Public Health Requirements. J Bacteriol Parasitol. 2013, S: 5-","journal-title":"J Bacteriol Parasitol"},{"issue":"Suppl 1","key":"4167_CR74","doi-asserted-by":"publisher","first-page":"S73","DOI":"10.1086\/338827","volume":"185","author":"JG Montoya","year":"2002","unstructured":"Montoya JG: Laboratory Diagnosis of Toxoplasma gondii Infection and Toxoplasmosis. J Infect Dis. 2002, 185 (Suppl 1): S73-S82. doi:10.1086\/338827","journal-title":"J Infect Dis"},{"issue":"2","key":"4167_CR75","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1590\/S0074-02762009000200038","volume":"104","author":"MH Bessieres","year":"2009","unstructured":"Bessieres MH, Berrebi A, Cassaing S, Fillaux J, Cambus JP, Berry A, Assouline C, Ayoubi JM, Magnaval JF: Diagnosis of congenital toxoplasmosis: prenatal and neonatal evaluation of methods used in Toulouse University Hospital and incidence of congenital toxoplasmosis. Mem Inst Oswaldo Cruz. 2009, 104 (2): 358-363. 10.1590\/S0074-02762009000200032. http:\/\/dx.doi.org\/10.1590\/S0074-02762009000200038 ,","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"1","key":"4167_CR76","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1258\/096914107780154440","volume":"14","author":"RE Gilbert","year":"2007","unstructured":"Gilbert RE, Thalib L, Tan HK, Paul M, Wallon M, Petersen E: [The European Multicentre Study on Congenital Toxoplasmosis- EMSCOT]. Screening for congenital toxoplasmosis: accuracy of immunoglobulin M and immunoglobulin A tests after birth. J Med Screen. 2007, 14 (1): 8-13. 10.1258\/096914107780154440.","journal-title":"J Med Screen"},{"issue":"6","key":"4167_CR77","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.1128\/JCM.39.6.2267-2271.2001","volume":"39","author":"JM Pinon","year":"2001","unstructured":"Pinon JM, Dumon H, Chemla C, Franck J, Petersen P, Lebech M, Zufferey J, Bessieres HM, Marty P, Holliman R, Johnson J, Luyasu V, Lecolier B, Guy E, Joynson DHM, Decoster A, Enders G, Pelloux H, Candolfi E: Strategy for diagnosis of congenital toxoplasmosis: evaluation of methods comparing mothers and newborns and standard methods for postnatal detection of immunoglobulin G, M, and A antibodies. J Clin Microbiol. 2001, 39 (6): 2267-2271. 10.1128\/JCM.39.6.2267-2271.2001. doi:10.1128\/JCM.39.6.2267-2271.2001","journal-title":"J Clin Microbiol"},{"issue":"3","key":"4167_CR78","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1017\/S095026880400353X","volume":"133","author":"CG Carvalheiro","year":"2005","unstructured":"Carvalheiro CG, Mussi-Pinhata MM, Yamamoto AY, De Souza CB, Maciel LM: Incidence of congenital toxoplasmosis estimated by neonatal screening: relevance of diagnostic confirmation in asymptomatic newborn infants. Epidemiol Infect. 2005, 133 (3): 485-491. 10.1017\/S095026880400353X.","journal-title":"Epidemiol Infect"},{"key":"4167_CR79","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0301-2115(00)00300-6","volume":"94","author":"MH Bessi\u00e8res","year":"2001","unstructured":"Bessi\u00e8res MH, Berrebi A, Rolland M, Bloom MC, Roques C, Cassaing S, Courjault C, S\u00e9gu\u00e9la JP: Neonatal screening for CT in a cohort of 165 women infected during pregnancy and influence of in utero treatment on the results of neonatal tests. Eur J Obstet Gynecol Reprod Biology. 2001, 94: 37-45. 10.1016\/S0301-2115(00)00300-6.","journal-title":"Eur J Obstet Gynecol Reprod Biology"},{"issue":"4","key":"4167_CR80","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/S0002-9378(99)70311-X","volume":"181","author":"W Foulon","year":"1999","unstructured":"Foulon W, Pinon JM, Stray-Pedersen B, Pollak A, Lappalainen M, Decoster A, Villena I, Jenum PA, Hayde M, Naessens A: Prenatal diagnosis of congenital toxoplasmosis: a multicenter evaluation of different diagnostic parameters. Am J Obstet Gynecol. 1999, 181 (4): 843-847. 10.1016\/S0002-9378(99)70311-X.","journal-title":"Am J Obstet Gynecol"},{"key":"4167_CR81","first-page":"137","volume":"107","author":"B Knerer","year":"1995","unstructured":"Knerer B, Hayde M, Gratz G, Bernaschek G, Strobl W, Pollak A: Direct detection of Toxoplasma gondii with polymerase chain reaction in diagnosis of fetal toxoplasma infection. Wien Klin Wochenschr. 1995, 107: 137-140.","journal-title":"Wien Klin Wochenschr"},{"key":"4167_CR82","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1590\/S0037-86822002000100001","volume":"35","author":"PVT Vidigal","year":"2002","unstructured":"Vidigal PVT, Santos DVV, Castro FC, Couto JCF, Vitor RWA, Brasileiro FG: Prenatal toxoplasmosis diagnosis from amniotic fluid by PCR. Rev Soc Bras Med Trop. 2002, 35: 1-6. 10.1590\/S0037-86822002000100001.","journal-title":"Rev Soc Bras Med Trop"},{"issue":"5","key":"4167_CR83","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1111\/j.1471-0528.2005.00486.x","volume":"112","author":"L Thalib","year":"2005","unstructured":"Thalib L, Gras L, Romand S, Prusa A, Bessieres MH, Petersen E, Gilbert RE: Prediction of congenital toxoplasmosis by polymerase chain reaction analysis of amniotic fluid. BJOG. 2005, 112 (5): 567-574. 10.1111\/j.1471-0528.2005.00486.x.","journal-title":"BJOG"},{"key":"4167_CR84","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1128\/JCM.28.10.2297-2301.1990","volume":"28","author":"CM Grover","year":"1990","unstructured":"Grover CM, Thulliez P, Remington JS, Boothroyd JC: Rapid prenatal diagnosis of congenital Toxoplasma infection by using polymerase chain reaction and amniotic fluid. J Clin Microbiol. 1990, 28: 2297-2301.","journal-title":"J Clin Microbiol"},{"issue":"2","key":"4167_CR85","first-page":"160","volume":"50","author":"CA Alford Jr","year":"1974","unstructured":"Alford CA, Stagno S, Reynalds DW: Congenital toxoplasmosis: clinical, laboratory and therapeutic considerations with special reference to subclinical disease. Bull NY Acad. 1974, 50 (2): 160-181.","journal-title":"Bull NY Acad"},{"issue":"8","key":"4167_CR86","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1097\/00006454-199808000-00009","volume":"17","author":"M Wallon","year":"1998","unstructured":"Wallon M, Caudie C, Rubio S, Bellini L, Girault V, Gay-Andrieu F, Peyron F: Value of cerebrospinal fluid cytochemical examination for the diagnosis of congenital toxoplasmosis at birth in France. Pediatr Infect Dis J. 1998, 17 (8): 705-710. 10.1097\/00006454-199808000-00009.","journal-title":"Pediatr Infect Dis J"},{"key":"4167_CR87","first-page":"1445","volume":"19","author":"G Desmonts","year":"1990","unstructured":"Desmonts G, Couvreur J, Thulliez P: Toxoplasmose conge\u2019nitale: cinq cas de transmission a\u2032 l\u2019enfant d\u2019une infection maternelle ante\u2018rieure \u00e0\u2019 la grossesse. Presse Med. 1990, 19: 1445-1449.","journal-title":"Presse Med"},{"issue":"1","key":"4167_CR88","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1590\/S0021-75572010000100015","volume":"86","author":"GM Andrade","year":"2010","unstructured":"Andrade GM, Vasconcelos-Santos DV, Carellos EV, Romanelli RM, Vitor RW, Carneiro AC, Januario JN: Congenital toxoplasmosis from a chronically infected woman with reactivation of retinochoroiditis during pregnancy. J Pediatr. 2010, 86 (1): 85-88. 10.1590\/S0021-75572010000100015. doi:10.2223\/JPED.1948. Epub 2009 Nov 16","journal-title":"J Pediatr"},{"key":"4167_CR89","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1086\/595793","volume":"199","author":"A Elbez-Rubinstein","year":"2009","unstructured":"Elbez-Rubinstein A, Ajzenberg D, Dard\u00e9 M-L, Cohen R, Dum\u00e8tre A, Yera H, Gondon H, Janaud J-C, Thulliez P: Congenital Toxoplasmosis and Reinfection during pregnancy: Case report, strain characterization, experimental model of reinfection, and review. J Infect Dis. 2009, 199: 280-285. 10.1086\/595793. doi:10.1086\/595793","journal-title":"J Infect Dis"},{"issue":"7","key":"4167_CR90","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.arcped.2011.04.011","volume":"18","author":"V Vald\u00e8s","year":"2011","unstructured":"Vald\u00e8s V, Legagner H, Watrin V, Paris L, Hascoet JM: Congenital toxoplasmosis due to maternal reinfection during pregnancy. Arch Pediatr. 2011, 18 (7): 761-763. 10.1016\/j.arcped.2011.04.011.","journal-title":"Arch Pediatr"},{"key":"4167_CR91","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.ejogrb.2007.09.010","volume":"136","author":"EL Gollub","year":"2008","unstructured":"Gollub EL, Leroy V, Gilbert R, Chene G, Wallon M: Effectiveness of health education on Toxoplasma-related knowledge, behaviour, and risk of seroconversion in pregnancy. Eur J Obstet Gynecol Reprod Biol. 2008, 136: 137-145. 10.1016\/j.ejogrb.2007.09.010.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"4","key":"4167_CR92","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.puhe.2007.08.009","volume":"122","author":"HM Elsheikha","year":"2008","unstructured":"Elsheikha HM: Congenital toxoplasmosis: priorities for further health promotion action. Public Health. 2008, 122 (4): 335-353. 10.1016\/j.puhe.2007.08.009.","journal-title":"Public Health"},{"issue":"5","key":"4167_CR93","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1590\/S1413-86702003000500007","volume":"7","author":"MA Saf\u00e1di","year":"2003","unstructured":"Saf\u00e1di MA, Berezin EN, Farhat CK, Carvalho ES: Clinical presentation and follow up of children with congenital toxoplasmosis in Brazil. Braz J Infect Dis. 2003, 7 (5): 325-331.","journal-title":"Braz J Infect Dis"},{"issue":"1","key":"4167_CR94","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1590\/S0037-86822012000100011","volume":"45","author":"JA Soares","year":"2012","unstructured":"Soares JA, Carvalho SF, Caldeira AP: Profile of pregnant women and children treated at a reference center for congenital toxoplasmosis in the northern state of Minas Gerais, Brazil. Rev Soc Bras Med Trop. 2012, 45 (1): 55-59. 10.1590\/S0037-86822012000100011.","journal-title":"Rev Soc Bras Med Trop"},{"issue":"2","key":"4167_CR95","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1590\/S0074-02762009000200032","volume":"104","author":"J Melamed","year":"2009","unstructured":"Melamed J: Contributions to the history of ocular toxoplasmosis in Southern Brazil. Mem Inst Oswaldo Cruz. 2009, 104 (2): 383-388. 10.1590\/S0074-02762009000200037. http:\/\/dx.doi.org\/10.1590\/S0074-0276200900020003 ,","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"9","key":"4167_CR96","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1097\/INF.0b013e31821b8dfe","volume":"30","author":"F Kieffer","year":"2011","unstructured":"Kieffer F, Rigourd V, Ikounga P, Bessieres B, Magny JF, Thulliez P: Disseminated congenital toxoplasma infection with a type II strain. Pediatr Infect Dis J. 2011, 30 (9): 813-815. 10.1097\/INF.0b013e31821b8dfe. doi:10.1097\/INF.0b013e31821b8dfe","journal-title":"Pediatr Infect Dis J"},{"issue":"4","key":"4167_CR97","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/S0929-693X(03)00034-4","volume":"10","author":"F Cneude","year":"2003","unstructured":"Cneude F, Deli\u00e8ge R, Barbier C, Durand-Joly I, Bourlet A, Sonna M, El Kohen R, Locquet A, Vittu G, Decoster A: Septic shock due to congenital disseminated toxoplasmosis?. Arch Pediatr. 2003, 10 (4): 326-328. 10.1016\/S0929-693X(03)00034-4.","journal-title":"Arch Pediatr"},{"issue":"6","key":"4167_CR98","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1097\/MAO.0b013e31828297b6","volume":"34","author":"M Salviz","year":"2013","unstructured":"Salviz M, Montoya JG, Nadol JB, Santos F: Otopathology in congenital toxoplasmosis. Otol Neurotol. 2013, 34 (6): 1165-1169. 10.1097\/MAO.0b013e31828297b6. doi:10.1097\/MAO.0b013e31828297b6","journal-title":"Otol Neurotol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2334-14-33\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-14-33.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-14-33","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-14-33.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,9]],"date-time":"2023-07-09T22:38:59Z","timestamp":1688942339000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/1471-2334-14-33"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,18]]},"references-count":98,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["4167"],"URL":"https:\/\/doi.org\/10.1186\/1471-2334-14-33","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,18]]},"article-number":"33"}}